-
An experimental blood oxygenation device has the potential to help thousands of patients with severe emphysema or other lung conditions. The device has been thoroughly tested in laboratory animals, but human trials would involve major invasive procedures for research participants and place them at very high risk of death or serious complications.
-
A recent court ruling in a lawsuit may mean that home health agencies will be required to provide notice to Medicare patients whenever services are reduced or discontinued.
-
People caring for profoundly ill children must meet their patients social, psychological, and spiritual needs as well as their medical needs, say the authors of an article published in the April 22 issue of the New England Journal of Medicine.
-
-
The Centers for Disease Control and Prevention (CDC) reports the third documented clinical isolate of vancomycin-resistant Staphylococcus aureus (VRSA) from a patient in the United States. There are also troubling indications that emerging VRSA may not be detected by commonly used automated antimicrobial susceptibility testing, CDC warns.
-
Fueled in part by the third case of vancomycin-resistant Staphylococcus aureus (VRSA) in the United States, William Jarvis, MD, urges more aggressive hospital surveillance measures than those currently recommended nationally by the CDC.
-
The Association for Professionals in Infection Control and Epidemiologys (APIC) position paper on disclosure of nosocomial infection rates includes key points summarized in this article.
-
-
According to UNAIDS in Geneva, the HIV/AIDS epidemic is growing despite the worlds attention and efforts at increasing prevention and treatment efforts.
-
UCB Pharma Inc. and the Food and Drug Administration recently issued a Dear health care professional letter advising health care professionals of the risk of dispensing errors between lopinavir/ritonavir (Kaletra), an antiretroviral, and levetiracetam (Keppra), an antiepileptic drug.
